TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
PAI Partners has agreed to acquire British skincare brand Elemis from L’Occitane Group, with completion expected in the first quarter of 2027 pending regulatory approvals. Financial terms were not disclosed. Elemis reported more than $300 million in net sales in fiscal 2026, according to the source report.
PAI Partners has agreed to acquire Elemis from L’Occitane Group, ending the skincare brand’s seven-year period under L’Occitane ownership and setting up a change in ownership expected to complete in the first quarter of 2027. The deal, announced November 4, 2026, remains subject to regulatory approvals; financial terms have not been disclosed.
Elemis is a British prestige skincare brand. Since L’Occitane acquired it in 2019, its annual net sales have nearly doubled to more than US$300 million in fiscal 2026, according to the report. The source material does not provide the brand’s profit, valuation or the purchase price agreed by PAI.
The report says the United States accounts for about 50 percent of Elemis revenue, while digital channels contribute nearly half of sales. PAI plans to strengthen the company’s position in the UK, pursue further US growth and expand digital and premium retail distribution. It also intends to continue investing in the Pro-Collagen skincare portfolio.
The agreement is a planned acquisition, not a completed sale. Completion is anticipated in the first quarter of 2027, subject to regulatory clearance. Until then, L’Occitane remains the owner, and the parties have not published details about the transaction’s financial structure or any operational changes during the approval period.
Elemis’s Next Growth Priorities
The deal gives PAI Partners control of a skincare business with established international sales and a substantial US presence. Its stated priorities point to growth through UK market development, US expansion and broader digital and premium retail distribution, rather than a disclosed shift in product focus. Continued investment in Pro-Collagen is also part of PAI’s stated plan.
For L’Occitane Group, the sale is a portfolio decision that ends its ownership of Elemis, though the company has not provided a public explanation in the supplied material for its decision to sell. The transaction also reflects private equity interest in established prestige beauty brands. That wider interpretation is not a guarantee of future performance: the source gives no forecast for Elemis’s sales, profits or expansion pace under PAI.
For customers and retail partners, the immediate practical effect is limited: the deal has not yet closed, and no changes to products, pricing, distribution agreements or staffing were announced in the source report. Those details could matter as the ownership handover approaches, but they remain unreported.
Products Worth Considering
LEVOIT Vital Pet Pro Smart Air Purifier
Philips Sonicare 5950 Rechargeable Electric Toothbrush with 2 Brush Heads, Pink
Therabody Theragun Relief Massage Gun, 3-Speed, Black
As an affiliate, we earn on qualifying purchases.
Elemis Under L’Occitane Ownership
L’Occitane Group acquired Elemis in 2019. The company’s sales growth since then is a central part of the case for the proposed purchase: the report says annual net sales nearly doubled to more than US$300 million in fiscal 2026. It does not specify the exact starting sales figure or provide a year-by-year breakdown, so the comparison cannot be independently detailed from the information available here.
The brand’s business is concentrated in two channels and markets highlighted by the report: the US represents about half of revenue, and digital sales make up nearly half of total sales. PAI’s stated plan to grow in the UK and extend digital and premium retail distribution would build on those existing features while seeking a broader market reach. The announcement gives no specific targets, deadlines beyond the anticipated deal completion, or investment amounts for these plans.
The transaction announcement was reported by Global Cosmetics News, citing PAI Partners as its source. The available report confirms the announced agreement and broad strategic intentions, but it does not include statements from L’Occitane or detailed transaction documents.
“PAI Partners plans to strengthen Elemis’s UK market position, accelerate US growth and expand digital and premium retail distribution.”
— PAI Partners, as reported by Global Cosmetics News
Price, Approvals and Operating Changes
The purchase price and other financial terms remain undisclosed, and the source material does not identify the regulatory authorities involved or provide a timetable for their review. The anticipated first-quarter 2027 completion is therefore conditional, not a confirmed closing date.
It is also unclear whether PAI will make changes to Elemis’s leadership, workforce, product range, pricing or retail relationships after completion. The report sets out plans for market and channel growth and continued Pro-Collagen investment, but it does not say how those plans will be funded or measured. No sales or profit forecasts under PAI have been provided.
The source report attributes the announcement to PAI Partners and does not include a direct statement from L’Occitane Group. Its reasons for selling Elemis, and any intended use of proceeds, are not specified in the material available.
Regulatory Review and Closing
The next key milestone is regulatory review. The parties expect the transaction to complete in the first quarter of 2027 if required approvals are obtained. Until closing, the agreement remains pending, and the source does not describe any interim management or operating arrangements.
Further details to watch for include disclosure of the financial terms, confirmation of regulatory clearance and an announcement that the sale has closed. After completion, updates from PAI and Elemis may clarify how the buyer intends to carry out its plans for UK and US growth, digital sales, premium retail and the Pro-Collagen portfolio. No such post-closing steps or targets have yet been specified in the supplied report.
Key Questions
Who has agreed to acquire Elemis?
PAI Partners has agreed to acquire the British skincare brand from L’Occitane Group. The transaction has not yet closed.
When is the Elemis acquisition expected to close?
The deal is expected to complete in the first quarter of 2027, subject to regulatory approvals. This is an expected period, not a confirmed closing date.
How much is PAI Partners paying for Elemis?
The purchase price and other financial terms have not been disclosed in the source report.
What does PAI plan to do with Elemis?
PAI says it plans to strengthen Elemis in the UK, pursue further US growth, expand digital and premium retail distribution, and continue investing in the Pro-Collagen portfolio. Specific targets were not provided.
How has Elemis performed under L’Occitane?
The report says Elemis’s annual net sales nearly doubled after L’Occitane acquired it in 2019, reaching more than US$300 million in fiscal 2026. It also says the US accounts for about half of revenue and digital channels generate nearly half of sales.
Source: globalcosmeticsnews.com
